These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Adding banding ligation is effective as rescue therapy to prevent variceal rebleeding in haemodynamic non-responders to pharmacological therapy. González A; Augustin S; Dot J; Pérez M; Abu-Suboh M; Romero A; Segarra A; Armengol JR; Esteban R; Guardia J; Genescà J Dig Liver Dis; 2012 Jan; 44(1):55-60. PubMed ID: 21890439 [TBL] [Abstract][Full Text] [Related]
6. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. de la Peña J; Brullet E; Sanchez-Hernández E; Rivero M; Vergara M; Martin-Lorente JL; Garcia Suárez C Hepatology; 2005 Mar; 41(3):572-8. PubMed ID: 15726659 [TBL] [Abstract][Full Text] [Related]
7. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Lo GH; Lai KH; Cheng JS; Chen MH; Huang HC; Hsu PI; Lin CK Hepatology; 2000 Sep; 32(3):461-5. PubMed ID: 10960435 [TBL] [Abstract][Full Text] [Related]
8. Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy. Villanueva C; Aracil C; Colomo A; Lopez-Balaguer JM; Piqueras M; Gonzalez B; Torras X; Guarner C; Balanzo J Aliment Pharmacol Ther; 2009 Feb; 29(4):397-408. PubMed ID: 19006538 [TBL] [Abstract][Full Text] [Related]
9. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study. Abecasis R; Kravetz D; Fassio E; Ameigeiras B; Garcia D; Isla R; Landeira G; Dominguez N; Romero G; Argonz J; Terg R Hepatology; 2003 Feb; 37(2):359-65. PubMed ID: 12540786 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension. La Mura V; Abraldes JG; Raffa S; Retto O; Berzigotti A; García-Pagán JC; Bosch J J Hepatol; 2009 Aug; 51(2):279-87. PubMed ID: 19501930 [TBL] [Abstract][Full Text] [Related]
11. Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Sauer P; Hansmann J; Richter GM; Stremmel W; Stiehl A Endoscopy; 2002 Sep; 34(9):690-7. PubMed ID: 12195325 [TBL] [Abstract][Full Text] [Related]
12. Preventing first variceal hemorrhage in cirrhosis. Albillos A J Clin Gastroenterol; 2007; 41 Suppl 3():S305-11. PubMed ID: 17975481 [TBL] [Abstract][Full Text] [Related]
13. A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis. Villanueva C; Graupera I; Aracil C; Alvarado E; Miñana J; Puente Á; Hernandez-Gea V; Ardevol A; Pavel O; Colomo A; Concepción M; Poca M; Torras X; Reñe JM; Guarner C Hepatology; 2017 May; 65(5):1693-1707. PubMed ID: 28100019 [TBL] [Abstract][Full Text] [Related]
14. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Monescillo A; Martínez-Lagares F; Ruiz-del-Arbol L; Sierra A; Guevara C; Jiménez E; Marrero JM; Buceta E; Sánchez J; Castellot A; Peñate M; Cruz A; Peña E Hepatology; 2004 Oct; 40(4):793-801. PubMed ID: 15382120 [TBL] [Abstract][Full Text] [Related]
15. Measuring the hemodynamic response to primary pharmacoprophylaxis of variceal bleeding: a cost-effectiveness analysis. Imperiale TF; Chalasani N; Klein RW Am J Gastroenterol; 2003 Dec; 98(12):2742-50. PubMed ID: 14687827 [TBL] [Abstract][Full Text] [Related]
16. Acute and chronic hemodynamic changes after propranolol in patients with cirrhosis under primary and secondary prophylaxis of variceal bleeding: a pilot study. de-Madaria E; Palazón JM; Hernández FT; Sánchez-Paya J; Zapater P; Irurzun J; de España F; Pascual S; Such J; Sempere L; Carnicer F; García-Herola A; Valverde J; Pérez-Mateo M Eur J Gastroenterol Hepatol; 2010 May; 22(5):507-12. PubMed ID: 20150817 [TBL] [Abstract][Full Text] [Related]
17. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension. Escorsell A; Bordas JM; Castañeda B; Llach J; García-Pagán JC; Rodés J; Bosch J Hepatology; 2000 May; 31(5):1061-7. PubMed ID: 10796880 [TBL] [Abstract][Full Text] [Related]
18. Prognostic role of the initial portal pressure gradient reduction after TIPS in patients with cirrhosis. Biecker E; Roth F; Heller J; Schild HH; Sauerbruch T; Schepke M Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):846-52. PubMed ID: 17873607 [TBL] [Abstract][Full Text] [Related]
19. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. La Mura V; Abraldes JG; Berzigotti A; Erice E; Flores-Arroyo A; García-Pagán JC; Bosch J Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998 [TBL] [Abstract][Full Text] [Related]
20. [Therapeutic efficacy of transjugular intrahepatic portosystemic shunt on bleeding gastric varices]. Song HG; Lee HC; Park YH; Jung S; Chung YH; Lee YS; Yoon HK; Sung KB; Suh DJ Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):448-57. PubMed ID: 12506249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]